Low-Dose Enzalutamide in Metastatic Prostate Cancer—Longevity Over Conventional Survival Analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Low-Dose Enzalutamide in Metastatic Prostate Cancer—Longevity Over Conventional Survival Analysis

Published:2022-12 Issue:6 Volume:20 Page:e473-e484
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Vinh-Hung Vincent^ORCID,Gorobets Olena,Natchagande Gilles,Sargos Paul,Yin Ming,Nguyen Nam P.,Verschraegen Claire^ORCID,Folefac Edmund

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference39 articles.

1. The effect of age on cancer-specific mortality in patients with prostate cancer: a population-based study across all stages;Knipper;Cancer Causes Control,2020

2. Effect of comorbidity on prostate cancer-specific mortality: a prospective observational study;Rajan;J Clin Oncol,2017

3. Comorbidities, treatment and ensuing survival in men with prostate cancer;Chamie;J Gen Intern Med,2012

4. Age dependence of modern clinical risk groups for localized prostate cancer—a population-based study;Huynh-Le;Cancer,2020

5. Prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology;Mohler;J Natl Compr Canc Netw,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Prospective Randomised Trial to Determine the Effect of a Reduced Versus Standard Dose of Enzalutamide on Side Effects in Frail Patients with Prostate Cancer;European Urology Oncology;2024-03

2. Low-Dose Apalutamide in Nonmetastatic Castration-Resistant Prostate Cancer: A Case Report;Cureus;2024-02-14

3. Comparison of standard-dose and reduced-dose treatment of metastatic prostate cancer with enzalutamide, apalutamide or darolutamide: a rapid review;BMJ Oncology;2024-02

4. Androgen receptor pathway inhibitors, prostate cancer, and older adults: a global Young International Society of Geriatric Oncology drug review;Therapeutic Advances in Medical Oncology;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3